Development of a Chemoresistant Risk Scoring Model for Prechemotherapy Osteosarcoma Using Single-Cell Sequencing

Development of a Chemoresistant Risk Scoring Model for Prechemotherapy Osteosarcoma Using Single-Cell Sequencing

BackgroundChemoresistance is one of the leading causes that severely limits the success of osteosarcoma treatment. Evaluating chemoresistance before chemotherapy poses a new challenge for researchers. We established an effective chemoresistance risk scoring model for prechemotherapy osteosarcoma usi...

Full description

Bibliographic Details
Main Authors: Ziliang Zeng, Wenpeng Li, Di Zhang, Chi Zhang, Xu Jiang, Rui Guo, Zheyu Wang, Canchun Yang, Haolin Yan, Zhilei Zhang, Qiwei Wang, Renyuan Huang, Qiancheng Zhao, Bo Li, Xumin Hu, Liangbin Gao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Oncology
Subjects:
osteosarcoma
single-cell RNA sequencing
chemoresistance
heterogeneity
stemness
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.893282/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.893282/full

Similar Items